Status:
TERMINATED
Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.
Lead Sponsor:
University of Rochester
Conditions:
Blood Coagulation Disorder
Eligibility:
All Genders
1-18 years
Phase:
PHASE1
Brief Summary
Investigate the validity of Hemosense System in pediatric patients on anticoagulation therapy.
Detailed Description
Over the last few decades there has been an increased use of Warfarin in the pediatric population stemming from the use of mechanical heart valves and palliative surgical procedures requiring anticoag...
Eligibility Criteria
Inclusion
- \- All pediatric patient requiring Warfarin therapy.
Exclusion
- Subjects older then 18 year of age.
- Pregnant subjects.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00288808
Start Date
October 1 2005
End Date
June 1 2006
Last Update
April 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Strong Medical Center
Rochester, New York, United States, 14642